ICYMI, some of this week’s featured content includes articles on the multiple modalities to revise scars, the future of dermatology, phase 3 results of tapinarof cream for plaque psoriasis, guidelines for the COVID-19 vaccine and dermal fillers, plus more.
This week’s edition of The Mainstream Patient features stories on hidradenitis suppurativa, the rise of contact dermatitis, sebaceous filaments, coconut oil for the face, plus more.
Treatment regimens for pediatric acne should consider skin type, ethnicity, disease severity and personal preferences, according to one expert.
In this month's Cosmetic Conundrums column, Dermatology Times Chief Medical Editor Zoe Diana Draelos, MD, details the difference between cosmetic moisturizers and pharmaceutical vehicles.
From lasers to filler and microneedling, dermatologists have a broad menu of modalities for addressing the challenges of scars.
Three experts chart game-changing innovations that will shift the boundaries of dermatology.
In the Moderna coronavirus disease 2019 (COVID-19) vaccine trials, 3 participants reported facial or lip swelling after receiving the vaccine. ASDS guidelines state that patients with a history of dermal filler injections should not void vaccinations.
In this episode, Gary Salman, CEO of Black Talon Security, details how to best protect your practice from data breaches and cybercriminals, as well as the risks of not implementing cybersecurity measures into your practice and what to do if a data or email breach occurs.
Dermavant announces positive results from an interim analysis of its PSOARING 3 safety study investigating tapinarof cream 1% for the treatment of plaque psoriasis in adult patients.
Joel Cohen, MD, gives a synopsis of a panel discussion he was recently a part of at the 2021 ODAC Dermatology, Aesthetic and Surgical Conference focusing on the postoperative treatment of scars using a variety of methods including lasers, filler and other modalities.
ASDSA has issued a patient safety alert after videos surface online of children/teens self-injecting HA via “hyaluron pens”.
New treatments for atopic dermatitis offer more options with favorable safety and efficacy.
Patients with rosacea can get better results by supplementing standard minocycline oral therapy with γ-linolenic acid (GLA), according to findings from a recent study.